Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

WONDFO

Wondfo is a high-tech biological company focusing providing professional products and services for rapid diagnosis an... read more Featured Products: More products

Download Mobile App





Wondfo Presents Advanced Solutions in CLIA Testing and Blood Gas Analysis

By LabMedica International staff writers
Posted on 13 Nov 2024

Wondfo (Guangzhou, China) is presenting a variety of new products at MEDICA 2024, including its new FC-2100 fully automatic chemiluminescence immunoassay analyzer, the Finecare FIA Meter X1 and X2 fluorescence immunoassay analyzer, and the Ucare-6000 automatic blood gas analyzer. More...

With its precision and efficiency, FC-2100 is attracting a lot of attention at this year’s MEDICA. As a desktop fully-automatic chemiluminescence immunoassay analyzer, it only covers 0.64 sqm, which is more flexible and convenient and can be installed and placed in almost all laboratory operating tables. It has a test speed of up to 200T/hour and shows the first result within 12 minutes. Wondfo’s new immunofluorescence platform, Finecare X Series-FS-1000 & FS-2000, is accurate, efficient, and easy to use. Its motto is “One-Step Operation, Always One Step Ahead.” The X series supports whole blood sample testing. Taking into account the different needs of labs, this new platform offers single-channel (X1) and multi-channels (X2) for options. Its hs-cTnI sensitivity of 20pg/ml enables labs to provide more effective support for acute and critical diseases. Wondfo is also showcasing its colloidal gold Strep A Test Kit which is available for both self-testing and professional use. The Wondfo One Step Strep A Swab Test is a rapid chromatographic immunoassay for the qualitative detection of group A streptococcal antigen from throat swab specimens and is intended for use as an aid in the diagnosis of group A streptococcal infection.

Visitors to the Wondfo booth are also showing great interest in the Ucare-6000 automatic blood gas analyzer which enjoys efficiency, flexibility, and simplified operation. The integration of the electrode cartridge with the reagent bag simplifies the testing operation to one-step sample loading and reduces the cost of individual test cartridges. The Ucare-6000 features an expansive menu comprising 34 parameters of blood gas, electrolytes, metabolites, and Hct, and features a built-in battery that allows 6-hour standby. In addition, Wondfo is highlighting the PA-3600 fully automated IHC staining system that has been independently developed by the company. The PA-3600 is suitable for a wide range of sample types, and can automatically complete the entire process of immunohistochemical staining from baking to re-staining. Since its official launch in 2021, it has been widely used in hospitals, research institutes, ICLs (Independent Clinical Laboratory), pharmaceutical CROs, and other organizations, and has gained recognition for its excellent performance and quality.

Related Links:
Wondfo


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: iStock

AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health

Advances in molecular diagnostics are creating new opportunities to improve the detection of sexually transmitted infections, identify antibiotic resistance, and assess cancer recurrence risk in women.... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.